On Cancer

Print
and/or
41 Blog posts found

In the Lab

Forensic Techniques Enable Study of Individual Breast Cancer Cells from MSK’s Archives

Analysis of long-preserved single cells on pathology slides aims to provide new clues about the genes that make breast cancer more aggressive.

Pathology slide showing DCIS and invasive cancer

In the Clinic

How Research Is Driving the Latest Treatments for Sarcoma

Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.

MSK Surgeon Aimee Crago

In the Clinic

What’s New in Leiomyosarcoma?

In this Q&A, medical oncologist Martee Hensley discusses the diagnosis and treatment of leiomyosarcoma and other uterine sarcomas.

Leiomyosarcoma expert Martee Hensley

In the Clinic

Powerful Tumor DNA Test Has Guided Cancer Treatment for 10,000 MSK Patients

Learn how MSK’s powerful new tumor DNA test has helped guide treatment decisions for more than 10,000 people with advanced cancer.

Three scientists look up at ascreen showing genetic information about a tumor.

In the Lab

Rapid Results: MSK Researchers Link Genetic Mutation to Rare Bladder Cancer

MSK researchers have identified a genetic mutation that plays a central role in a rare, aggressive form of bladder cancer called plasmacytoid variant carcinoma.

David Solit

In the Clinic

Less Is More: MSK Surgeons Reduce Lymph Node Removal for Endometrial Cancer

A new study validates the effectiveness of sentinel lymph node mapping to guard against cancer spread.

Yellow-green fluorescent dye marking a lymph node among pink tissue in the uterus.

Finding

Collaborative Research Suggests Targeting BAP1 May Help Treat Mesothelioma

Studies have suggested that treatment with a drug that targets a mutated gene found in more than half of all mesothelioma tumors could be effective against this stubborn disease.

CT scan of mesothelioma tumor.

In the Clinic

Aggressive Lung Adenocarcinoma Subtype May Require New Treatment Strategy

Some early-stage lung adenocarcinoma patients have an aggressive subtype that often returns after surgery, even when tumors are small.

Microscopic image of adenocarcinoma lung cancer cells

Q&A

What’s New in Liposarcoma?

Medical oncologist Mark Dickson discusses the latest in liposarcoma care and the research he and his colleagues are conducting to improve patients’ treatment options.

Close-up of medical oncologist Mark Dickson, who treats liposarcoma and other types of sarcomas.

Announcement

Expanding the Impact of Precision Medicine to Fuel Discoveries

MSK’s Functional Genomics Initiative will enable basic scientists to take full advantage of the massive amount of data produced by tumor sequencing.

Christina Leslie and John Petrini